Profound symptomatic bradycardia associated with combined mibefradil and beta-blocker therapy.
作者信息
Rogers R, Prpic R
机构信息
Sir Charles Gairdner Hospital, Nedlands, WA.
出版信息
Med J Aust. 1998 Oct 19;169(8):425-7.
PMID:9830391
Abstract
We report two cases where the addition of mibefradil to long term beta-blocker therapy in managing hypertension produced profound symptomatic bradycardia requiring cardiac pacing. Reports of a number of interactions between mibefradil and other cardioactive drugs have now led to its withdrawal from the market worldwide.
摘要
Zotero 插件